BDBM50192266 (S)-N-(3,5-bis(trifluoromethyl)benzyl)-2-(4-fluorophenyl)-4-(4-(thiophen-3-yl)piperidin-1-yl)butanamide::CHEMBL215515
SMILES: Fc1ccc(cc1)[C@H](CCN1CCC(CC1)c1ccsc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F
InChI Key: InChIKey=YVYCNZXAEFCTJA-VWLOTQADSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM50192266![]() ((S)-N-(3,5-bis(trifluoromethyl)benzyl)-2-(4-fluoro...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of [125I]MCP1 binding to CCR2 expressed in CHO cells | J Med Chem 49: 4801-4 (2006) Article DOI: 10.1021/jm060439n BindingDB Entry DOI: 10.7270/Q2VQ329M | |||||||||||
More data for this Ligand-Target Pair |